1 Transplant Unit, Royal Papworth Hospital NHS Foundation Trust, Cambridge, United Kingdom.
2 Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
3 Department of Pathology, Royal Papworth Hospital NHS Foundation Trust, Cambridge, United Kingdom.
4 BHF Center for Cardiovascular Sciences, University of Edinburgh, Edinburgh, United Kingdom.
5 Usher Institute, University of Edinburgh, Edinburgh, United Kingdom.
Received 16 April 2021. Revision received 26 May 2021.
Accepted 6 June 2021.
K.K.L. has received an honorarium unrelated to this research from Abbotts Diagnostics and N.L.M. has received honorarium and grants unrelated to this research, from Abbots Diagnostics, Roche Diagnostics, and Siemens Healthcare. The other authors declare no conflicts of interest.
S.J.F. proposed the research, participated in the research design, data analysis, and writing of the article. J.D.W.E. participated in the data analysis and writing of the article. D.M.R., K.K.L., and F.E.S. participated in data collection and reviewing of the article. J.P. and N.L.M. participated in data collection, research design and reviewing of the article. S.J.P. participated in the research design, data analysis, and writing of the article.
Supplemental digital content (SDC) is available for this article. Direct URL citations appear in the printed text, and links to the digital files are provided in the HTML text of this article on the journal’s Web site (www.transplantjournal.com).
Correspondence: Sarah J Fitzsimons, MBChB, FRACP, Cardiology Department, Auckland City Hospital, 2 Park Rd, Grafton, Auckland, New Zealand 1023. ([email protected]).
